Clinical Trial Update: Improving Fibrosis Outcomes With Metformin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating metformin for fibrosis outcomes has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: HIV Infection, Hepatitis C | Phase 2 | Status: WITHDRAWN